Preventing influenza in younger children.

作者: S. Esposito , C. Tagliabue , L. Tagliaferri , M. Semino , M.R. Longo

DOI: 10.1111/J.1469-0691.2012.03942.X

关键词: VaccinationPandemicEpidemiologyMedical prescriptionInfluenza vaccineEconomic consequencesPediatricsHuman mortality from H5N1Live attenuated influenza vaccineMedicine

摘要: Influenza is common in infants and children: attack rates vary from 23% to 48% each year during inter-pandemic periods, are even higher pandemics. Severe cases occur more frequently children with underlying chronic diseases; however, epidemiological studies have clearly shown that influenza also causes an excess of medical examinations, drug prescriptions hospitalizations otherwise healthy (particularly those aged <5 years), as well a considerable number paediatric deaths. Childhood has social economic consequences. However, many European health authorities still reluctant include vaccinations their national vaccination programmes for because, among other things, there doubts concerning real ability evoke protective immune response, especially the first years life. New hope solution these problems come introduction vaccines containing antigens possibility intradermal administration. further needed establish whether universal life should be recommended, which vaccine.

参考文章(70)
Kathleen M. Neuzil, Yuwei Zhu, Marie R. Griffin, Kathryn M. Edwards, Juliette M. Thompson, Sharon J. Tollefson, Peter F. Wright, Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25-Year Prospective Study The Journal of Infectious Diseases. ,vol. 185, pp. 147- 152 ,(2002) , 10.1086/338363
Robert B. Belshe, Kathryn M. Edwards, Timo Vesikari, Steven V. Black, Robert E. Walker, Micki Hultquist, George Kemble, Edward M. Connor, Live attenuated versus inactivated influenza vaccine in infants and young children. The New England Journal of Medicine. ,vol. 356, pp. 685- 696 ,(2007) , 10.1056/NEJMOA065368
Terho Heikkinen, Heli Silvennoinen, Ville Peltola, Thedi Ziegler, Raija Vainionpää, Tytti Vuorinen, Leena Kainulainen, Tuomo Puhakka, Tuomas Jartti, Pia Toikka, Pasi Lehtinen, Taina Routi, Taina Juvén, Burden of Influenza in Children in the Community The Journal of Infectious Diseases. ,vol. 190, pp. 1369- 1373 ,(2004) , 10.1086/424527
Isaac Benowitz, Daina B. Esposito, Kristina D. Gracey, Eugene D. Shapiro, Marietta Vázquez, Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their Infants Clinical Infectious Diseases. ,vol. 51, pp. 1355- 1361 ,(2010) , 10.1086/657309
S. Esposito, L. Pugni, C. Daleno, A. Ronchi, A. Valzano, D. Serra, F. Mosca, N. Principi, Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Pediatrics. ,vol. 127, ,(2011) , 10.1542/PEDS.2010-1920
Emmanuel B. Walter, Shilpa Rajagopal, Yuwei Zhu, Kathleen M. Neuzil, Mary P. Fairchok, Janet A. Englund, Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally? Vaccine. ,vol. 28, pp. 4376- 4383 ,(2010) , 10.1016/J.VACCINE.2010.04.058
Douglas M Fleming, Pietro Crovari, Ulrich Wahn, Timo Klemola, Yechiel Schlesinger, Alexangros Langussis, Knut Øymar, Maria Luz Garcia, Alain Krygier, Herculano Costa, Ulrich Heininger, Jean-Louis Pregaldien, Sheau-Mei Cheng, Jonathan Skinner, Ahmad Razmpour, Melanie Saville, William C Gruber, Bruce Forrest, CAIV-T Asthma Study Group, None, Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatric Infectious Disease Journal. ,vol. 25, pp. 860- 869 ,(2006) , 10.1097/01.INF.0000237797.14283.CF
W. P. Glezen, Emerging Infections: Pandemic Influenza Epidemiologic Reviews. ,vol. 18, pp. 64- 76 ,(1996) , 10.1093/OXFORDJOURNALS.EPIREV.A017917
Danuta M Skowronski, Travis S Hottes, Mei Chong, Gaston De Serres, David W Scheifele, Brian J Ward, Scott A Halperin, Naveed Z Janjua, Tracy Chan, Suzana Sabaiduc, Martin Petric, Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months Pediatrics. ,vol. 128, ,(2011) , 10.1542/PEDS.2010-2777